Early IV Magnesium for Moderate Asthma Attacks in Children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of administering magnesium sulfate within the first hour of treatment for children aged 5-17 experiencing moderate asthma exacerbations. Patients presenting to the OU Children's Hospital Emergency Department will be assessed and those with a respiratory score indicating moderate exacerbation will be approached for consent. Eligible participants will be randomized to receive either early magnesium sulfate treatment or standard care as determined by their provider. The study aims to evaluate outcomes such as length of stay in the emergency department and hospital, as well as the need for respiratory support.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Ages 5-17 years old
* Presents to the ED with a respiratory score in the "Moderate" range (6
* Parent(s)/Caregiver(s) speak English

Exclusion Criteria:

* Patients with chronic medical conditions including chronic pulmonary disease (other than asthma), cerebral palsy, congenital heart disease, tracheostomy dependent, myasthenia gravis patients
* Patients who are pregnant
* Parent(s)/Caregiver(s) do not speak English

Where it's running

• Oklahoma Children's Hospital
  Oklahoma City, Oklahoma, United States Recruiting

Study contacts

• Principal investigator: Ryan McKee, MD — University of Oklahoma
• Study coordinator: Ryan McKee, MD
• Email: ryan-mckee@ouhsc.edu
• Phone: 4056308997

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Remote monitoring for managing chronic respiratory diseases like asthma

  This study is testing if a new remote monitoring system can help people with asthma manage their symptoms better and reduce the number of asthma attacks.

  Recruiting SingHealth Polyclinics · Singapore · NCT06377345

• N-WATCH: Can a simple breath device help monitor asthma in kids

  This study tests the N-Tidal C device to see if it helps monitor asthma in children aged 5 to under 16 who have wheeze or asthma and are not critically ill.

  Recruiting at 2 sites University of Nottingham · Nottingham, Nottinghamshire and 1 other locations · NCT07833826

• Smart Inhaler Use at Home for Adolescents with IDD and Asthma

  This study tests whether daily use of active smart inhalers at home helps adolescents with intellectual disabilities manage asthma better.

  Recruiting Children's Hospital Los Angeles · Los Angeles, California · NCT07746921

• Post-Exacerbation Asthma Telecare

  This trial tests whether a structured remote pulmonology follow-up after an asthma flare‑up can reduce repeat exacerbations compared with usual care.

  Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT07629830

• ASMact: Managing bronchial asthma attacks in children

  This study tries a GINA 2025-based staff education and care-standardization approach to see if emergency treatment for children aged 6–17 with acute asthma attacks improves outcomes.

  Recruiting at 2 sites Meyer Children's Hospital IRCCS · Ferrara, FE and 1 other locations · NCT07412769

• Boosting referrals to asthma specialists after an ER visit

  This study tests whether arranging a telehealth follow-up with an asthma specialist from the ER helps adults with asthma see a specialist within 3 months more often than usual referrals.

  Recruiting University of South Florida · Tampa, Florida · NCT07396987

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.